Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

Clinical evidence — real world results Transcatheter Aortic Valve Implantation (TAVI)

EXCELLENT RESULTS DEMONSTRATED IN REAL-WORLD SETTINGS

Data indicates the Medtronic TAVI platform clinical performance provides reproducible results and performs well over time.

FORWARD Study
ADVANCE Study

FORWARD STUDY¹

This multicenter, prospective, single-arm, observational post-market study evaluated the safety and performance of the Evolut R system in a routine hospital setting.

Study Status/Duration: 12-month outcomes reported/3-year follow-up
Sample Size: N = 1040
Devices: Evolut R TAV

1 year hemodynamic data
Valve Performance

SEE DATA (opens new window)

30-day procedural outcomes
All Cause Rates

ADVANCE Study²

ADVANCE is a multicenter, prospective, single-arm, observational study to evaluate safety and performance of the CoreValve™ system in a routine clinical setting.

Study Status/Duration: 5-year outcomes reported/5-year follow-up
Sample Size: N = 1,015
Devices: CoreValve, TAV

SEE STUDY DATA (opens new window)

Graph showing effective orifice area and mean gradient over 5 years.
View Larger(opens new window)

For a summary of all TAVI clinical studies, see Clinical Evidence Compendium

Contact us

CLICK HERE (opens new window)

Lifeline cardiovascular technical support

rs.cstechsupport@medtronic.com

Medtronic Academy

View more clinical data and access procedural resources.

EDUCATION & RESOURCES

Find additional feature information, educational resources, and tools.

VISIT MEDTRONIC ACADEMY (opens new window)

Grube, as presented at EuroPCR 2018

Gerckens U, Tamburino C, Bleiziffer S, et al. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J. September 21, 2017;38(36):2729-2738.